Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Richard Strutz who wrote (1212)	2/7/2000 2:35:00 PM
From: William Partmann	Respond to of 1686

Richard, I am not a professional so do you own "due diligence". However, in response to your question, I believe Biogen will outperform the market for the next couple of months and possibly year. It will be very volatile during that time. And should there be a spring/early summer correction, I would expect a 20-30% sell-off which should correspond to the average tech stock fall. Avonnex usage is expanding but the street also wants a "pipeline". This, in my opinion, is the disconcerting factor of BGEN. We just don't know. Just my humble opinion. Good luck. Bill